Cargando…
Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision Oncology
Autor principal: | Jadvar, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126444/ https://www.ncbi.nlm.nih.gov/pubmed/30030344 http://dx.doi.org/10.2967/jnumed.118.213470 |
Ejemplares similares
-
A Precision Medicine Approach to SARS-CoV-2 Pandemic Management
por: Crisci, Carlos D., et al.
Publicado: (2020) -
Oncology During the COVID-19 Pandemic: a Lockdown Perspective
por: Boniface, Danielle, et al.
Publicado: (2022) -
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)
por: Cheung, Carol C., et al.
Publicado: (2019) -
Precision Medicine Starts With Preanalytics: Real-Time Assessment of Tissue Fixation Quality by Ultrasound Time-of-Flight Analysis
por: Lerch, Melissa L., et al.
Publicado: (2017) -
Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated Pathways
por: Rosenthal, Samantha L., et al.
Publicado: (2014)